Acute treatment and prevention of menstrually related migraine headache

@article{Pringsheim2008AcuteTA,
  title={Acute treatment and prevention of menstrually related migraine headache},
  author={Tamara Pringsheim and William Jeptha Davenport and David W. Dodick},
  journal={Neurology},
  year={2008},
  volume={70},
  pages={1555 - 1563}
}
Menstrually related migraine (MRM) headache is common in women and associated with substantial disability. Compared to nonmenstrual migraine, MRM attacks are more severe, longer in duration, and have a poorer response to analgesics. The purpose of this guideline is to provide a systematic review and meta-analysis of the existing therapy trials for MRM and evidence-based recommendations for acute and short-term preventive treatment of MRM headache. Prospective, double-blind, randomized… 
Clinical aspects of perimenstrual headaches
  • F. Taylor
  • Medicine
    Current pain and headache reports
  • 2009
TLDR
Triptan mini-prophylaxis outcomes are positive, but a conclusion of “minimal net benefit compared to placebo” is not entirely unwarranted.
Clinical Trials Report: Sumatriptan–Naproxen Combination for Symptomatic Treatment of Comorbid Dysmenorrhea and Migraine
  • E. MacGregor
  • Medicine, Psychology
    Current pain and headache reports
  • 2010
TLDR
Sumatriptan was the first triptan to be developed of seven triptans currently available, with established efficacy for symptomatic treatment of migraine, and has been shown to be more effective in restoring normal function following treatment than either sum atriptan or naproxen sodium alone.
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan
TLDR
Frovatriptan proved to be effective in the immediate treatment of MRM attacks, similarly to zolmitriptan, but showed lower recurrence rates, and thus a better sustained relief.
Progress in the Pharmacotherapy of Menstrual Migraine
TLDR
The evidence for acute and prophylactic drugs in the management of menstrual migraine is reviewed and future therapeutic options are considered.
Prevention and Treatment of Menstrual Migraine
TLDR
There is evidence that menstrual attacks are more severe, longer, less responsive to treatment, more likely to relapse and associated with greater disability than attacks at other times of the cycle, and prophylactic strategies can reduce the frequency and severity of attacks and acute treatment is more effective.
A review of the use of frovatriptan in the treatment of menstrually related migraine
TLDR
Frovatriptan has now gained a grade A recommendation from the guidelines for short-term prophylaxis of MM, characterized by a more sustained and prolonged effect than other triptans, with the lowest risk of treatment-emergent adverse events.
Menstrual Migraine: Update on Pathophysiology and Approach to Therapy and Management
  • A. Calhoun
  • Medicine
    Current Treatment Options in Neurology
  • 2011
TLDR
In the author’s experience, hormonal preventives are the best approach for most women whose menstrual attacks are resistant to acute therapy and afford the greatest therapeutic benefit in prevention while treating common comorbidities and allowing for acute treatment with triptans when needed.
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan
TLDR
Frovatriptan was as effective as riz atriptan in the immediate treatment of menstrually related migraine attacks while showing a favorable sustained effect with a lower rate of migraine recurrence.
Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting
TLDR
Results suggest that migraine prevention with topiramate in a general practice is generally well tolerated and associated with a significant improvement in migraine headaches and related functional impairment.
The Effect of Migraine Prophylaxis on Migraine-Related Resource Use and Productivity
TLDR
Overall, there is a need to improve quality of care in migraine, and prophylactic therapy appears to be an effective option, particularly with respect to decreasing resource use and improving productivity, and topiramate seems to be a cost-effective intervention for preventing migraine.
...
...

References

SHOWING 1-10 OF 40 REFERENCES
Efficacy of oral naratriptan in the treatment of menstrually related migraine
TLDR
Naratriptan given orally at a dose of 2.5 mg is effective in the acute treatment of MRM as early as 2 h after treatment, and patient overall satisfaction is found.
Treatment of Menstruation-Associated Migraine Headache With Subcutaneous Sumatriptan
TLDR
Sumatriptan was as effective and well tolerated for menstruation-associated migraine as it was for nonmenstrual migraine and treated nausea and photophobia more effectively in menstrual-migraine patients than did placebo.
Rizatriptan for the Acute Treatment of ICHD-II Proposed Menstrual Migraine: Two Prospective, Randomized, Placebo-Controlled, Double-Blind Studies
TLDR
Rizatriptan 10 mg was effective for the treatment of ICHD-II menstrual migraine, as measured by 2-h pain relief and 24-h sustained pain relief.
Efficacy and Tolerability of Zolmitriptan Oral Tablet in the Acute Treatment of Menstrual Migraine
TLDR
Oral zolmitriptan is effective and well tolerated for the acute treatment of menstrual migraine attacks and the results are similar to those seen with zolMITriptan in studies of the general migraine population.
Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine.
Prevention of menstrual attacks of migraine
TLDR
Although perimenstrual percutaneous estradiol showed benefit during treatment, this was offset by deferred estrogen withdrawal, triggering post-dosing migraine immediately after the gel was stopped, and further work could assess if this could be avoided by extending the duration of treatment with est radiol.
Efficacy and tolerability of sumatriptan tablets administered during the mild‐pain phase of menstrually associated migraine
TLDR
Data suggest that—with menstrually associated migraine as with non‐menstrual migraine—optimal therapeutic benefit of sumatriptan tablets may be realised when they are administered during the mild‐pain phase of an attack rather than delaying treatment until headache is moderate or severe.
...
...